BTN3A1 expressed in cervical cancer cells promotes Vγ9Vδ2 T cells exhaustion through upregulating transcription factors NR4A2/3 downstream of TCR signaling

Jian Liu,Min Wu,Yifan Yang,Xinyu Mei,Liming Wang,Jingyu Wang,Zixuan Wang,Shan He,Hangyu Liu,Han Jiang,Shen Qu,Yuwei Zhang,Ying Chen,Xun Tian,Yafei Huang,Hui Wang
DOI: https://doi.org/10.1186/s12964-024-01834-0
IF: 7.525
2024-09-30
Cell Communication and Signaling
Abstract:Clinical trials have shown that immunotherapy based on Vγ9Vδ2 T cells (Vδ2 T cells) is safe and well-tolerated for various cancers including cervical cancer (CC), but its overall treatment efficacy remains limited. Therefore, exploring the mechanisms underlying the suboptimal efficacy of Vδ2 T cell-based cancer immunotherapy is crucial for enabling its successful clinical translation.
cell biology
What problem does this paper attempt to address?